title: Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose.
authors.forename: Lina
authors.initials: L
authors.lastname: Quteineh
authors.forename: Celine
authors.initials: C
authors.lastname: Verstuyft
authors.forename: Christelle
authors.initials: C
authors.lastname: Descot
authors.forename: Liliane
authors.initials: L
authors.lastname: Dubert
authors.forename: Annie
authors.initials: A
authors.lastname: Robert
authors.forename: Patrice
authors.initials: P
authors.lastname: Jaillon
authors.forename: Laurent
authors.initials: L
authors.lastname: Becquemont
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000483:Alleles; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D016022:Case-Control Studies; D062787:Drug Overdose; D005260:Female; D014644:Genetic Variation; D005838:Genotype; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D006899:Mixed Function Oxygenases / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011446:Prospective Studies; D012307:Risk Factors; D013927:Thrombosis / Q000188:drug therapy; D064417:Vitamin K Epoxide Reductases
chemical_list: D000925:Anticoagulants; D006899:Mixed Function Oxygenases; C578523:VKORC1 protein, human; D064417:Vitamin K Epoxide Reductases